Isaac Y. Kim, MD, PhD

The Cancer Institute of New Jersey (CINJ) 195 Little Albany Street New Brunswick, NJ 08901 kimiy@umdnj.edu

Clinical Specialty: Laparoscopy, Oncology, Robotics

Degree

• PhD from Northwestern University Graduate School
• MD from Northwestern University Medical School

Grants

• Role of bone morphogenetic protein receptors type II in prostate cancer cells. (UMDNJ Foundation)
• Immuno-gene therapy for prostate cancer based on transforming growth factor-B insensitive macrophages. (New York Academy of Medicine)
• BMP-6 and Prostate Cancer (Tanzman Foundation)
• BMP-6 and neuroendocrine differentiation in prostate cancer (New Jersey Commission on Cancer Research)

Positions

• Associate Professor (12/2009 - Present)
  Cell and Developmental Biology
  UMDNJ Graduate School of Biomedical Sciences, New Brunswick, NJ.
• Executive Director (11/2009 - Present)
  Dean and Betty Gallo Prostate Cancer Center/Robert Wood Johnson Medical Scho
  The Cancer Institute of New Jersey
• Assistant Professor (08/2005 - Present)
  Urologic Oncology
  The Cancer Institute of New Jersey, Robert Wood Johnson Medical School
• Director of Minimally Invasive, Laparoscopic and Robotic Surgery, Urologic Oncology (11/2006 - 03/2008)
  Urologic/Oncology
  The Cancer Institute of New Jersey, Robert Wood Johnson Medical School
• Chief & Associate Professor (03/2008 - Present)
  Division of Urologic/Oncology
  The Cancer Institute of New Jersey

Honors

• AUA/Praecis Pharmaceuticals Gerald P. Murphy Scholar, 98th
  American Urological Association (2003)
• Outstanding Laparoendoscopic Resident Surgeon
  The Society of Laparoendoscopic Surgeons (2003)
• Clinical Fellow, 2004
  AACR/ASCO (2004)
• Edwin Beer Research Fellowship
  New York Academy of Medicine (2006)

Society

• Endourological Society (2005 - Present)
• American College of Surgeons (2005 - Present)
• Endocrine Society (1996 - Present)
• American Association for Cancer Research (1996 - Present)
• American Urological Association (1997 - Present)
• American Medical Association (2003 - Present)

Publications

• Isaac Yi Kim, Byung Chul Kim, Do Hwan Seong, Dug Keun Lee, Jeong Meen Seo, Heung Tae Kim, Ronald A. Morton, and Seong-Jin Kim. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines. Cancer Research. 2002; 62:5365-5369.
• Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, Byung-Chul Kim, Heung Tae Kim, Fredrick S. Leach, W. Marston Linehan, Ronald A. Morton and Seong-Jin Kim. Decreased expression of bone morphogenetic protein receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells. Clinical Cancer Research. 2003; 9:6046-6051.
• Isaac Yi Kim, Dong-Hyeon Lee, Han-Jong Ahn, Moses M. Kim, Seong-Jin Kim, and Ronald A Morton. Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells. Oncogene. 2004; 23:7651-7659.
• Isaac Yi Kim, Dong-Hyeon Lee, Dug Keun Lee, Wun Jae Kim, Moses M. Kim, Ronald A. Morton, Seth P. Lerner, and Seong Jin Kim. Restoration of bone morphogenetic proteins receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line, TSU-Pr1. Cancer Rsearch. 2004; 64:7355-7360.
• Isaac Yi Kim, Louis Eichel, Robert Edwards, Carlos Uribe, David S. Chou, Corollos Abdelshehid, Mike Ahlering, Shannon White, Edward Woo, Elspeth, McDougall, and Ralph V. Clayman. Effects of commonly used hemostatic agents in the pig urinary collecting system Journal of Endourology. 2007; 21:652-654.